Primary Immune Deficiency
23
3
6
11
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
4.3%
1 terminated out of 23 trials
91.7%
+5.2% vs benchmark
43%
10 trials in Phase 3/4
27%
3 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (23)
Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
Primitive Immunodeficiency and Pregnancy
Biologics And Clinical Immunology Cohort at Sinai
Study to Evaluate the Pharmacokinetics, Efficacy, Tolerability, and Safety of Subcutaneous Human Immunoglobulin (Newnorm) in Patients With Primary Immunodeficiency Diseases
Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults
Characterizing the Upper Airway Manifestations in Primary Ciliary Dyskinesia and Primary Immunodeficiencies
Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency
COVID-19 Vaccine Responses in PIDD Subjects
COVID-19 in PID Survey
Evaluation of Adult Patients With Immunodeficiency Within the Scope of the ICF
Evaluating Bronchodilator Response in Patients With Bronchiectasis
An Open Label, Multicenter Study to Evaluate the Pharmacokinetics, Efficacy and Safety of ASCENIV™ (IGIV) in Pediatric Subjects With Primary Immunodeficiency Diseases (PIDD)
A Prospective Monocentric Study to Assess the Concordance of Lung MRI Compared to Chest CT Scan to Assess the Extent and Severity of Bronchial and Parenchymal Pulmonary Lesions in Adult Patients With Primary Immune Deficiency (PID) .
Antibody Production in Immune Disorders
Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation
Study of Immune Deficiency Patients Treated With Subcutaneous Immunoglobulin (IgPro20, Hizentra®) on Weekly and Biweekly Schedules
Determinants of Health Status and Quality of Life in Patients With Primary Immunodeficiencies Inhereted Diagnosed During Childhood
Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)
Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study)
Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID)